GlaxoSmithKline Pharmaceuticals Limited

NSE GLAXO.NS

GlaxoSmithKline Pharmaceuticals Limited Shareholders' Equity for the year ending March 31, 2024: USD 213.12 M

GlaxoSmithKline Pharmaceuticals Limited Shareholders' Equity is USD 213.12 M for the year ending March 31, 2024, a 0.59% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

GlaxoSmithKline Pharmaceuticals Limited Shareholders' Equity for the year ending March 31, 2023 was USD 211.86 M, a -39.59% change year over year.
GlaxoSmithKline Pharmaceuticals Limited Shareholders' Equity for the year ending March 31, 2022 was USD 350.71 M, a 71.30% change year over year.
GlaxoSmithKline Pharmaceuticals Limited Shareholders' Equity for the year ending March 31, 2021 was USD 204.73 M, a -15.26% change year over year.
GlaxoSmithKline Pharmaceuticals Limited Shareholders' Equity for the year ending March 31, 2020 was USD 241.59 M, a -21.54% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

NSE: GLAXO.NS

GlaxoSmithKline Pharmaceuticals Limited

CEO	Mr. Bhushan Akshikar
IPO Date	July 1, 2002
Location	India
Headquarters	GSK House
Employees	3,211
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care Vaccines

Description

GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact, Tenovate, Flutivate, Physiogel, Zimig, Cobadex CZS, Infanrix Hexa, Synflorix, Supacef, Havrix, Menveo, Boostrix, Fluarix Tetra, Varilrix, Nucala, and Trelegy Ellipta brands. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.

Key trends

Past 5 years